InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →James M Frates, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 11 open-market SEC Form 4 transactions: 1 purchase worth $101K and 10 sales worth $2.4M, reported from Jan 6, 23 to Mar 2, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 26 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 7.9K | $14.52 | $115K |
| Feb 2, 26 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 3.6K | $14.65 | $52K |
| Jan 6, 26 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 3.3K | $11.11 | $37K |
| Sep 30, 25 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 10.6K | $14.65 | $155K |
| Mar 31, 25 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 10.9K | $3.47 | $38K |
| Sep 12, 24 | AMLXAmylyx Pharmaceuticals, Inc. | BUY | 40.0K | $2.53 | $101K |
| Mar 5, 24 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 1.8K | $18.73 | $34K |
| Jan 9, 24 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 2.7K | $16.33 | $44K |
| May 16, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 32.0K | $27.60 | $862K |
| Mar 16, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 30.8K | $32.46 | $981K |
| Jan 6, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 1.8K | $36.79 | $66K |